Financhill
Back

Adaptimmune Therapeutics PLC Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
29

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.80
Seasonality Move:
35.83%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Adaptimmune Therapeutics PLC Price Quote

$0.80
+0.00 (+2.97%)
(Updated: November 9, 2024 at 5:10 AM ET)

Adaptimmune Therapeutics PLC Key Stats

Sell
29
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Day range:
$0.75 - $0.80
52-week range:
$0.42 - $2.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.35
P/B ratio:
2.12%

Volume:
687.1K
Avg. volume:
1.1M
1-year change:
41.6%
Market cap:
$203.8M
Revenue:
$60.3M
EPS:
$-0.3

How Much Does Adaptimmune Therapeutics PLC Make?

Is Adaptimmune Therapeutics PLC Growing As A Company?

Adaptimmune Therapeutics PLC Stock Price Performance

What Is Adaptimmune Therapeutics PLC 52-Week High & Low?

Adaptimmune Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Adaptimmune Therapeutics PLC?

Is Adaptimmune Therapeutics PLC Cash Flow Positive?

  • What Is ADAP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$44.4M
  • What Is Adaptimmune Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.4M
  • What Is Adaptimmune Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $124.4M

Adaptimmune Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    ADAP return on invested capital is -90.65%
  • What Is Adaptimmune Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -24.14%
  • What Is ADAP Return On Equity?
    ROE is a measure of profitability and is -96.68%

Adaptimmune Therapeutics PLC Earnings Date & Stock Price

Adaptimmune Therapeutics PLC Competitors

Adaptimmune Therapeutics PLC Dividend Yield

Adaptimmune Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 220.6%
Revenue: 2399.63% 186.47%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 2.74
Upside from Last Price: 243.69%

Major Shareholders

  • How many ADAP shares are owned by institutional investors?
    355.4M ADAP shares are owned by institutional investors
  • How many ADAP shares are owned by insiders?
    31.4M ADAP shares are owned by insiders